ABPS Integrative Medicine
CardiovascularEnglish
Exam overviewPractice session
In the REDUCE-IT trial, icosapent ethyl (Vascepa) 4 g/day reduced cardiovascular events in statin-treated patients with elevated triglycerides by approximately:
Loading your practice session…